Sera Prognostics Inc-A

Penny Stocks Biotech Stocks Healthcare Stocks

$1.72

-0.07 (-3.91%)

As of May 16, 9:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,870.3% upside

Low Target $29.33

Average Target $33.89

High Target $54.04

Current Price $1.72

Current
$1.72

Target
$33.89

$29.33 $33.89 avg $54.04

Scenario Analysis

Bear Case

$29.33

1,605.2%

Low target

Base Case

$33.89

+1,870.3%

Avg target

Bull Case

$54.04

+3,041.9%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$4.09

-57.9% from high

52-Week Low

$1.37

+25.5% from low

Target vs 52W High

$33.89

+728.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%